Argentina vs Iran (Islamic Republic of): Percentage of bloodstream infection due to methicillin-resistant
Argentina
32.8%
in 2022
Iran (Islamic Republic of)
34.7%
in 2022
Argentina rank
21st
Iran (Islamic Republic of) rank
19th
Percentage of bloodstream infection due to methicillin-resistant over time
- Argentina
- Iran (Islamic Republic of)
How they compare
Iran (Islamic Republic of) currently reports 34.7% against 32.8% in Argentina, a difference of 1.9%.
That makes Iran (Islamic Republic of)'s figure about 1.1 times Argentina's.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Argentina ahead.
Argentina ranks 21st and Iran (Islamic Republic of) ranks 19th of 50 countries.
Across the 2 decades both report, Argentina averaged higher in 1 and Iran (Islamic Republic of) in 1.
Head to head by decade
| Decade | Argentina | Iran (Islamic Republic of) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.3% | 38.8% | 3.5% | Argentina |
| 2020s | 35.2% | 37.2% | 2.0% | Iran (Islamic Republic of) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Argentina or Iran (Islamic Republic of)?
- Iran (Islamic Republic of), at 34.7% against 32.8% in Argentina as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Argentina and Iran (Islamic Republic of)?
- 1.9%, with Iran (Islamic Republic of) ahead.
- How many years of comparable data are there for Argentina and Iran (Islamic Republic of)?
- 5 years are reported by both, from 2018 to 2022.
- How do Argentina and Iran (Islamic Republic of) rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Argentina ranks 21st and Iran (Islamic Republic of) ranks 19th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.